Erythropoietin Crosses the Blood-Brain Barrier to Protect against Experimental Brain Injury

Authors: Brines, Michael L., Ghezzi, Pietro, Keenan, Sonja, Agnello, Davide, De Lanerolle, Nihal C., Cerami, Carla, Itri, Loretta M., Cerami, Anthony

Source: Proceedings of the National Academy of Sciences of the United States of America, 2000 Sep 01. 97(19), 10526-10531.

Access URL: https://www.jstor.org/stable/123595

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)

Authors: Agarwala, Sanjiv S., Keilholz, Ulrich, Gilles, Erard, Bedikian, Agop Y., Wu, Jane, Kay, Richard, Stein, Cy A., Itri, Loretta M., Suciu, Stefan, Eggermont, Alexander M.M.

Source: In European Journal of Cancer 2009 45(10):1807-1814

Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer.

Authors: Rugo, Hope S., Tolaney, Sara M., Loirat, Delphine, Punie, Kevin, Bardia, Aditya, Hurvitz, Sara A., O'Shaughnessy, Joyce, Cortés, Javier, Diéras, Véronique, Carey, Lisa A., Gianni, Luca, Piccart, Martine J., Loibl, Sibylle, Goldenberg, David M., Hong, Quan, Olivo, Martin, Itri, Loretta M., Kalinsky, Kevin

Source: NPJ Breast Cancer; 8/29/2022, Vol. 8 Issue 1, p1-10, 10p

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

Authors: Hong, Waun Ki, Lippman, Scott M., Itri, Loretta M.

Source: New England Journal of Medicine; September 20 1990, Vol. 323, p795-801, 7p

13-cis-retinoic acid in the treatment of oral leukoplakia.

Authors: Hong, Waun Ki, Endicott, James, Itri, Loretta M.

Source: New England Journal of Medicine; December 11 1986, Vol. 315, p1501-1505, 5p

The use of epoetin alfa in chemotherapy patients: A consistent profile of efficacy and safety

Authors: Itri, Loretta M.

Source: In Seminars in Oncology 2002 29(3) Supplement 8:81-87

TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors.

Authors: Tagawa, Scott T, Balar, Arjun V, Petrylak, Daniel P, Kalebasty, Arash Rezazadeh, Loriot, Yohann, Fléchon, Aude, Jain, Rohit K, Agarwal, Neeraj, Bupathi, Manojkumar, Barthelemy, Philippe, Beuzeboc, Philippe, Palmbos, Phillip, Kyriakopoulos, Christos E, Pouessel, Damien, Sternberg, Cora N, Hong, Quan, Goswami, Trishna, Itri, Loretta M, Grivas, Petros

Source: Journal of Clinical Oncology; 8/1/2021, Vol. 39 Issue 22, p2474-2485, 12p

Author Correction: Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer.

Authors: Rugo, Hope S., Tolaney, Sara M., Loirat, Delphine, Punie, Kevin, Bardia, Aditya, Hurvitz, Sara A., O'Shaughnessy, Joyce, Cortés, Javier, Diéras, Véronique, Carey, Lisa A., Gianni, Luca, Piccart, Martine J., Loibl, Sibylle, Goldenberg, David M., Hong, Quan, Olivo, Martin, Itri, Loretta M., Kalinsky, Kevin

Source: NPJ Breast Cancer; 6/6/2024, Vol. 10 Issue 1, p1-1, 1p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Fentanyl Iontophoretic Transdermal System (IONSYS(®)) can be Safely used in the Hospital Environment with X-Rays, Computerized Tomography and Radiofrequency Identification Devices.

Authors: Lemke, John, Sardariani, Edmond, Phipps, Joseph, Patel, Niki, Itri, Loretta, Caravelli, James, Viscusi, Eugene, Phipps, Joseph Bradley, Itri, Loretta M, Viscusi, Eugene R

Source: Advances in Therapy; Sep2016, Vol. 33 Issue 9, p1649-1659, 11p

Subject Terms: PAIN diagnosis, POSTOPERATIVE pain treatment, PAIN management, ANALGESICS, COMPUTED tomography, DRUG delivery systems, DRUG administration, FENTANYL, HEALTH, IONTOPHORESIS, NARCOTICS, PAIN, PATIENT-controlled analgesia, POSTOPERATIVE pain, RADIATION, RADIATION doses, RESEARCH funding, TRANSDERMAL medication, DIAGNOSIS

Geographic Terms: UNITED States

This result is not displayed to guests.
Login for full access.

Managing cancer‐related anaemia with epoetin alfa.

Authors: Itri, Loretta M.

Source: Nephrology Dialysis Transplantation; Jan2002 Supplement 1, Vol. 17, p73-77, 5p

Neuroprotective properties of epoetin alfa.

Authors: Cerami, Anthony, Brines, Michael, Ghezzi, Pietro, Cerami, Carla, Itri, Loretta M.

Source: Nephrology Dialysis Transplantation; Jan2002 Supplement 1, Vol. 17, p8-12, 5p

Cancer‐related anaemia requires higher doses of epoetin alfa than chronic renal failure replacement therapy.

Authors: Itri, Loretta M.

Source: Nephrology Dialysis Transplantation; Dec2001, Vol. 16 Issue 12, p2289-2293, 5p

Review.

Authors: Groopman, Jerome E., Itri, Loretta M.

Source: JNCI: Journal of the National Cancer Institute. 10/06/99, Vol. 91 Issue 19, p1616. 19p. 8 Charts.

Subject Terms: *ANEMIA, *DRUG therapy

Interferon-α2a in the Treatment of Acquired Immunodeficiency Syndrome-Related Kaposi's Sarcoma.

Authors: Evans, Lydia M., Itri, Loretta M., Campion, Marilyn, Wyler-Plaut, Ruth, Krown, Susan E., Groopman, Jerome E., Goldsweig, Howard, Volberding, Paul A., West, Susan B., Mitsuyasu, Ronald T., Dziewanowska, Zofia E.

Source: Journal of Immunotherapy; Feb1991, Vol. 10 Issue 1, p39-50, 12p

Cancer chemoprevention.

Authors: Itri, Loretta M.

Source: Cancer (0008543X); Dec1993 Supplement 11, Vol. 72 Issue S11, p3374-3380, 7p

13-cis-Retinoic Acid and Interferon α -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin.

Authors: Lippman, Scott M., Parkinson, David R., Itri, Loretta M., Weber, Randal S., Schantz, Stimson P., Ota, David M., Schusterman, Mark A., Krakoff, Irwin H., Gutterman, Jordan U., Hong, Waun Ki

Source: JNCI: Journal of the National Cancer Institute; 2/17/1992, Vol. 84 Issue 4, p235-241, 7p